This story originally appeared on The Mootley Fool. Up 64% and 34%, respectively, Tilray (NASDAQ:TLRY) and HEXO (NYSE:HEXO) are among the best-performing cannabis stocks in the industry over the past three months. And the momentum seems to be just getting started, as they both have massive upside potential going into 2021. When it comes to buying …Read More »
This story originally appeared on InvestmentNews. The global sustainable debt market grew 29% to a record $732 billion last year, helped by an explosion of bond issuance for social projects amid fallout from the pandemic, according to BloombergNEF. “Sustainability continues to rise up on the agenda for investors, businesses and …Read More »
This story originally appeared on MarketWatch. Moderna’s Covid-19 vaccine has been authorized for emergency use by the U.K. regulator, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regulatory Agency, or the MHRA, approved the two-shot vaccine developed by …Read More »
(This story is for CNBC PRO subscribers only.) We’re just seven days into the New Year, and Credit Suisse is already raising its forecast based on supportive Democratic policies and pent up demand once things return to normal from Covid. On Thursday the firm, led by chief U.S. equity strategist Jonathan Golub, …Read More »
This story originally appeared on StreetInsider. This year has been quite a doozie for marijuana stocks. 2020 started out looking like it would be a promising time for the cannabis market, but then the coronavirus quickly took its toll. Now, we are in the midst of a pandemic, and we continue …Read More »
Say you’re a Montana farmer who has planted acres of industrial hemp. As harvest nears, you’re looking to offload it. Where do you go to find a buyer? This story originally appeared on Marijuana Moment. Say you’re a Montana farmer who has planted acres of industrial hemp. As harvest nears, …Read More »
This story originally appeared on Forbes. When the pandemic began last Spring, Mary Jane’s Medicinals, which sells CBD and cannabis-infused topicals, took a big hit. April was “one of our worst months of sales ever,” said chief executive and founder Dahlia Mertens. A rebound soon followed though and by August sales …Read More »
This story originally appeared on The Fresh Toast. As cannabis becomes a go-to source for a myriad of health benefits, celebrity endorsements are normalizing the herb more than ever. Legally speaking, cannabis has slowly been making progress, shifting our cultural perspective so much so that it seems like celebrities openly …Read More »
This story originally appeared on Forbes. Federal Legalization Could Happen If Democrats Win Georgia’s Two Senate Seats In the January Run-off. Recreational and medical cannabis use ballot victories across the political spectrum this fall show marijuana’s acceptance continues to grow among American voters. Still, politicians mostly act along party lines. …Read More »
This story originally appeared on TheGrowthOp. The Thai government has proposed plans to remove the leaves, branches, stems, trunks, bark, fibre and roots of cannabis and hemp plants from the government’s narcotics list, opening the door for infused cosmetics and food products, reports the Bangkok Post. Notably, cannabis flower will remain …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!